Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years
Clinical trial NCT00788151 · COMPLETED
Trial details
- NCT number
- NCT00788151
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-26
- Primary completion
- 2010-02-16
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.